Page last updated: 2024-08-21

nicotinamide mononucleotide and Breast Neoplasms

nicotinamide mononucleotide has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bae, MG; Baur, JA; Brogren, D; Cho, CH; Choi, J; Corujo-Ramirez, A; Hawse, JR; Hou, X; Jang, MH; Kirkeby, LA; Oliveros, A; Rashid, MA; Tang, JJ; Weroha, SJ; Yoo, KH1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Breast Neoplasms

ArticleYear
Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.
    Cancer research, 2021, 07-01, Volume: 81, Issue:13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cisplatin; Cognitive Dysfunction; Female; Humans; Mice; Mice, SCID; Neuroprotective Agents; Nicotinamide Mononucleotide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021